Q4 EPS Forecast for Core Laboratories Lowered by Analyst

Core Laboratories Inc. (NYSE:CLB - Free Report) - Research analysts at Zacks Research decreased their Q4 2026 EPS estimates for Core Laboratories in a research note issued on Wednesday, May 14th. Zacks Research analyst R. Department now anticipates that the oil and gas company will post earnings per share of $0.28 for the quarter, down from their previous estimate of $0.34. The consensus estimate for Core Laboratories' current full-year earnings is $0.96 per share.

Core Laboratories (NYSE:CLB - Get Free Report) last issued its earnings results on Wednesday, April 23rd. The oil and gas company reported $0.14 earnings per share for the quarter, missing analysts' consensus estimates of $0.15 by ($0.01). Core Laboratories had a return on equity of 16.24% and a net margin of 5.99%. The business had revenue of $123.59 million for the quarter, compared to the consensus estimate of $125.09 million. During the same quarter in the previous year, the business posted $0.19 earnings per share. The company's quarterly revenue was down 4.7% on a year-over-year basis.

A number of other research analysts also recently weighed in on the stock. StockNews.com downgraded shares of Core Laboratories from a "hold" rating to a "sell" rating in a report on Friday, April 25th. Citigroup cut their target price on Core Laboratories from $16.00 to $13.00 and set a "neutral" rating on the stock in a report on Tuesday, May 13th. Finally, Stifel Nicolaus reduced their price target on Core Laboratories from $19.00 to $15.00 and set a "hold" rating for the company in a research report on Tuesday, April 15th. Two research analysts have rated the stock with a sell rating and three have issued a hold rating to the company's stock. Based on data from MarketBeat, the stock has an average rating of "Hold" and a consensus price target of $15.00.

Core Laboratories Trading Up 0.2%

Shares of NYSE:CLB opened at $11.89 on Monday. The firm has a fifty day moving average of $13.01 and a two-hundred day moving average of $16.44. The company has a quick ratio of 1.71, a current ratio of 2.32 and a debt-to-equity ratio of 0.49. Core Laboratories has a 12-month low of $10.14 and a 12-month high of $25.13. The firm has a market capitalization of $557.35 million, a P/E ratio of 18.01, a price-to-earnings-growth ratio of 0.99 and a beta of 1.45.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently made changes to their positions in CLB. JPMorgan Chase & Co. grew its holdings in shares of Core Laboratories by 5.8% in the 3rd quarter. JPMorgan Chase & Co. now owns 41,281 shares of the oil and gas company's stock valued at $765,000 after buying an additional 2,267 shares during the period. Nisa Investment Advisors LLC lifted its holdings in Core Laboratories by 2,688.5% during the fourth quarter. Nisa Investment Advisors LLC now owns 2,426 shares of the oil and gas company's stock worth $42,000 after acquiring an additional 2,339 shares in the last quarter. Boston Trust Walden Corp grew its stake in Core Laboratories by 2.7% in the fourth quarter. Boston Trust Walden Corp now owns 617,336 shares of the oil and gas company's stock valued at $10,686,000 after acquiring an additional 16,503 shares during the period. Van ECK Associates Corp grew its stake in Core Laboratories by 6.3% in the fourth quarter. Van ECK Associates Corp now owns 443,621 shares of the oil and gas company's stock valued at $7,679,000 after acquiring an additional 26,237 shares during the period. Finally, Principal Financial Group Inc. increased its holdings in shares of Core Laboratories by 3.1% in the fourth quarter. Principal Financial Group Inc. now owns 229,096 shares of the oil and gas company's stock worth $3,966,000 after acquiring an additional 6,827 shares in the last quarter. 97.81% of the stock is currently owned by institutional investors.

Core Laboratories Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, May 27th. Investors of record on Monday, May 5th will be paid a dividend of $0.01 per share. This represents a $0.04 dividend on an annualized basis and a dividend yield of 0.34%. The ex-dividend date of this dividend is Monday, May 5th. Core Laboratories's dividend payout ratio (DPR) is 6.78%.

Core Laboratories Company Profile

Core Laboratories Inc provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.